3rd Quarter - Report
MCDERMOTT WILL & SCHULTE LLP for GENOMIC HEALTH INC
Client
Income
$220,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EILEEN O'CONNOR | — |
| PAUL WILLIAM RADENSKY | — |
| SHEILA D WALCOFF | Committee, U.S. House of Representatives |
| ERIC ZIMMERMAN | — |
Health Issues HCR
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. Seeking TRICARE coverage for laboratory-developed tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CALVIN P JOHNSON | — |
| EILEEN O'CONNOR | — |
| PAUL WILLIAM RADENSKY | — |
| SHEILA D WALCOFF | Committee, U.S. House of Representatives |
| ERIC ZIMMERMAN | — |
Medical/Disease Research/Clinical Labs MED
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EILEEN O'CONNOR | — |
| PAUL WILLIAM RADENSKY | — |
| SHEILA D WALCOFF | Committee, U.S. House of Representatives |
| ERIC ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.